Galapagos NV ADR

Yahoo Finance • 8 days ago

Galapagos Announces Topline Results from Two Phase 3-Enabling Studies with Selective TYK2 Inhibitor GLPG3667 in Dermatomyositis and Systemic Lupus Erythematosus

GLPG3667 met primary endpoint in dermatomyositis study, demonstrating a statistically significant clinical benefit and meaningful improvements on secondary measures of disease activity compared to placebo In the systemic lupus erythematos... Full story

Yahoo Finance • 8 days ago

Galapagos maakt topline resultaten bekend van twee fase 3-enabling studies met selectieve TYK2-remmer GLPG3667 bij dermatomyositis en systemische lupus erythematodes

GLPG3667 bereikte het primaire eindpunt in de dermatomyositis-studie en toonde een statistisch significant klinisch voordeel en betekenisvolle verbeteringen aan op secundaire eindpunten van ziekteactiviteit in vergelijking met placebo In... Full story

Yahoo Finance • 19 days ago

Galapagos Presented New ATALANTA-1 Cell Therapy Data in MCL at ASH 2025

High complete response rates and minimal residual disease (MRD) negativity, with durable responses, in high-risk mantle cell lymphoma (MCL) with GLPG5101, a fresh, early memory-enriched CAR T-cell therapy with a 7-day vein-to-vein time Me... Full story

Yahoo Finance • 19 days ago

Galapagos presenteerde nieuwe ATALANTA-1 celtherapiedata in MCL op ASH 2025

Hoge percentages complete respons en minimale residuele ziekte (MRD)-negativiteit, met duurzame responsen, bij hoog-risico mantelcellymfoom (MCL) met GLPG5101, een verse, early-memory verrijkte CAR T-celtherapie met een vein-to-vein-tijd v... Full story

Yahoo Finance • last month

Galapagos Receives Transparency Notifications from Bank of America

Mechelen, Belgium; November 26, 2025, 07:30 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received transparency notifications from Bank of America. Pursuant to Belgian transparency legislation1, Galapagos received tr... Full story

Yahoo Finance • last month

Galapagos ontvangt transparantieverklaringen van Bank of America

Mechelen, België; 26 november 2025, 07:30 CET; gereglementeerde informatie – Galapagos NV (Euronext & NASDAQ: GLPG) heeft transparantieverklaringen ontvangen van Bank of America. Overeenkomstig de Belgische transparantiewetgeving1 ontving... Full story

Yahoo Finance • 2 months ago

Galapagos Announces Changes to its Board to Accelerate Strategic Focus on Business Development

Galapagos NV New Directors bring strong financial leadership, capital allocation, and business development expertise to the Board Mechelen, Belgium; October 30, 2025, 21:01 CET — Galapagos NV (Euronext & NASDAQ: GLPG), today announced se... Full story

Yahoo Finance • 2 months ago

Galapagos kondigt wijzigingen aan in de Raad van Bestuur om de strategische focus op business development te versnellen

Nieuwe bestuurders brengen sterke financiële leiderschapservaring, expertise in kapitaalallocatie en business development naar de Raad van Bestuur Mechelen, België; 30 oktober 2025, 21:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) kondig... Full story

Yahoo Finance • 2 months ago

Galapagos Announces Intention to Wind Down Cell Therapy Business as Part of the Company’s Ongoing Transformation

Intention follows comprehensive strategic review process and would represent the optimal capital allocation pathway to support a stronger and sustainable future for Galapagos Mechelen, Belgium; October 21, 2025, 07:30 CET; regulated infor... Full story

Yahoo Finance • 2 months ago

Galapagos kondigt intentie aan om celtherapieactiviteiten af te bouwen als onderdeel van de voortdurende transformatie van het bedrijf

Deze intentie volgt na een uitgebreid strategisch evaluatieproces en zou de meest optimale manier zijn om kapitaal toe te wijzen ter ondersteuning van een sterkere en duurzame toekomst voor Galapagos Mechelen, België; 21 oktober 2025, 07:... Full story

Yahoo Finance • 2 months ago

Galapagos Announces Appointment of Fred Blakeslee as General Counsel

Mechelen, Belgium; October 16, 2025, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced the appointment of Mr. Fred Blakeslee as Executive Vice President and General Counsel effective October 16, 2025. Blakeslee is succeedin... Full story

Yahoo Finance • 2 months ago

Galapagos kondigt benoeming aan van Fred Blakeslee als General Counsel

Mechelen, België; 16 oktober 2025, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) heeft vandaag de benoeming bekendgemaakt van de heer Fred Blakeslee tot Executive Vice President en General Counsel met ingang van 16 oktober 2025. Blakes... Full story

Yahoo Finance • 3 months ago

Galapagos Receives Non-Binding Offers For Cell Therapy Business

(RTTNews) - Galapagos NV (GLPG) said that it has received a limited number of non-binding offers from consortia—primarily composed of financial investors—expressing interest in acquiring the company's cell therapy business. The company con... Full story

Yahoo Finance • 3 months ago

Galapagos updates on strategic alternatives for cell therapy business

* Galapagos (NASDAQ:GLPG [https://seekingalpha.com/symbol/GLPG]) said on Wednesday that its board had decided to explore all strategic alternatives [https://seekingalpha.com/pr/20251932-galapagos-provides-update-on-strategic-alternatives... Full story

Yahoo Finance • 3 months ago

Galapagos Provides Update on Strategic Alternatives for Its Cell Therapy Business  

Mechelen, Belgium; October 1, 2025, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) and its Board of Directors today issued the following statement: On May 13, 2025, Galapagos announced that its Board of Directors (the “Board”) had deci... Full story

Yahoo Finance • 3 months ago

Galapagos geeft update over strategische alternatieven voor haar celtherapieactiviteiten

Mechelen, België; 1 oktober 2025, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) en haar Raad van Bestuur hebben vandaag de volgende verklaring uitgegeven: Op 13 mei 2025 kondigde Galapagos aan dat haar Raad van Bestuur (de “Raad”) had... Full story

Yahoo Finance • 4 months ago

Galapagos NV (GLPG)’ CAR-T Therapy Hits 97% Response Rate in Lymphoma Trial

In this article, we will be taking a look at the 11 Best Performing Biotech Stocks So Far in 2025. Galapagos NV is one of them. Galapagos NV (NASDAQ:GLPG) is a Belgian-based firm and is carving out a leading position in next-generation on... Full story

Yahoo Finance • 5 months ago

Galapagos Creates New Subscription Right Plan

Mechelen, Belgium; August 7, 2025, 22.01CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) announced today that its  Board of Directors created 1,800,000 subscription rights under a new subscription right plan. On August... Full story

Yahoo Finance • 5 months ago

Galapagos creëert nieuw inschrijvingsrechtenplan

Mechelen, België; 7 augustus 2025, 22.01 CET; gereglementeerde informatie – Galapagos NV (Euronext & NASDAQ: GLPG) kondigt vandaag aan dat haar Raad van Bestuur 1.800.000 inschrijvingsrechten heeft gecreëerd onder een nieuw inschrijvingsre... Full story

Yahoo Finance • 5 months ago

Galapagos NV Announces U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to GLPG5101 for the Treatment of Relapsed/Refractory Mantle Cell Lymphoma

Mechelen, Belgium; August 6, 2025, 7:30 CET; regulated information – inside information – Galapagos NV (Euronext & NASDAQ: GLPG) today announced that the United States Food and Drug Administration (FDA) has granted RMAT designation to GLPG... Full story